# Calcium Fracture Risk Meta-analysis: What the Evidence Says
Canonical: https://www.migaku.app/guides/calcium-fracture-risk-meta-analysis-evidence-review
Category: evidence-review
Summary: Calcium Fracture Risk Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are sys
Last reviewed: 2026-08-06
Reviewed by: Migaku Evidence Review
# Calcium Fracture Risk Meta-analysis: What the Evidence Says

## Quick Answer

Calcium Fracture Risk Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 2 systematic review.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Calcium, vitamin D, or combined supplementation to prevent fractures and falls: systematic review and meta-analysis | systematic review | 1 | 2026-01-01 | 10.1136/bmj-2025-088050 |
| Association of Dietary Approaches to Stop Hypertension Diet With the Risk of Osteoporosis and Fracture: A Systematic Review and Meta‐Analysis | systematic review | 1 | 2026-05-14 | 10.1002/fsn3.71892 |

## What The Sources Report

- Secondary outcomes included the risk of hip fracture, non-vertebral fracture, vertebral fracture, and falling, as well as the total number of falls. [Massé Olivier (2026); evidence level 1]
- If unpublished data, not obtained through personal communications, were found in another systematic review, we used that review to complete data extraction. [Massé Olivier (2026); evidence level 1]
- BMD DASH DXA FFQ NHLBI NOS 2011 2022 2020 2011 Osteoporosis is an important systemic skeletal disorder characterized by reduced bone mass, deterioration of bone microarchitecture, and increased bone fragility (Rachner et al. ). [Yang Bin (2026); evidence level 1]
- This trend underscores a growing public health burden as the disease and its related fractures can severely impair the long-term functioning and quality of life, eventually leading to a heightened risk of mortality (Dempster ). [Yang Bin (2026); evidence level 1]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For calcium fracture risk meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Massé Olivier (2026). Calcium, vitamin D, or combined supplementation to prevent fractures and falls: systematic review and meta-analysis. DOI: 10.1136/bmj-2025-088050. PMCID: PMC13188451. PMID: 42161415. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13188451/
- Yang Bin (2026). Association of Dietary Approaches to Stop Hypertension Diet With the Risk of Osteoporosis and Fracture: A Systematic Review and Meta‐Analysis. DOI: 10.1002/fsn3.71892. PMCID: PMC13176633. PMID: 42145829. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13176633/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.